| Issue Date | Title | Author(s) |
| 2016 | Anticholinergic activity and pharmacokinetic parameters of agent SS-68 with properties of class III antiarrhythmic drugs | Bogus, S. K.; Kulikov, A. L.; Vinakov, D. V.; Suzdalev, K. P.; Galenko-Yaroshevskii, P. A. |
| 2021 | Development and validation of eltrombopag determination in human plasma Blood by HPLC-MS Method | AL-Dhuraibi, A. M.; Kulikov, A. L.; Pokrovskiy, M. V. |
| 2016 | Development and validation of methods of quantitative determination of the new antidiabetic drug in the blood plasma of rats by high performance liquid chromatography with mass spectrometric detection | Buzov, A. A.; Kulikov, A. L.; Avtina, T. V.; Pokrovskii, M. V.; Osipova, O. A. |
| 2020 | Non-hematopoietic erythropoietin-derived peptides for atheroprotection and treatment of cardiovascular diseases | Belyaeva, V. S.; Stepenko, Yu. V.; Kulikov, A. L.; Kochkarova, I. S.; Martynova, O. V.; Pokrovskiy, M. V. |
| 2016 | Pharmacokinetic studies derived indole SS-68 with antiarrhythmic and antianginal properties | Galenko-Yaroshevsky, P. A.; Kulikov, A. L.; Vinakov, D. V.; Avtina, T. V.; Suzdalev, K. F. |
| 2016 | Pharmacokinetic studies of new antiparkinsonian drug Rapitalam | Avdeeva, N. V.; Kulikov, A. L.; Pokrovskii, M. V.; Avtina, T. V. |
| 2018 | Search and evaluation of pharmacodynamic and pharmacokinetic parameters of selective blocker of TRPA₁ ion channels from the group of substituted pyrazinopyrimidinones | Beskhmelnitsyna, E. A.; Dolzhikova, I. N.; Avtina, T. V.; Kulikov, A. L.; Rozhnova, D. V.; Yakushev, V. I.; Martynov, M. A. |
| 2019 | Tissue distribution of potential antidiabetic agent C7070 | Kulikov, A. L.; Pokrovskiy, M. V.; Kulikova, S. Y.; Kochkarova, I. S.; Dubcova, E. Yu. |
